Expertise in
27
conditions

Dr. Ashley B. Cauthen

Dermatology
Midstate Skin Institute LLC
17653 N Dale Mabry Hwy, 
Lutz, FL 
Accepting New Patients
Referral may be required
Before you request
Expertise in
27
conditions
Midstate Skin Institute LLC
17653 N Dale Mabry Hwy, 
Lutz, FL 

Overview

Ashley Cauthen is a Dermatologist practicing medicine in Lutz, Florida.

Dr. Cauthen is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Sunburn, Plaque Psoriasis, Telangiectasia, and Spider Angioma.

Dr. Cauthen is board certified in American Board Of Dermatology. She is actively involved in clinical research, co-authoring 5 peer reviewed articles and participating in 6 clinical trials. Dr. Cauthen is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in FL

Board Certifications

American Board Of Dermatology

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Dominion National
  • MEDICARE PDP
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MetLife
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 30 Less Insurance Carriers -

Locations

Midstate Skin Institute Llc
17653 N Dale Mabry Hwy, Lutz, FL 33548

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-1
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-1
Enrollment Status: Completed
Publish Date: September 25, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo- Controlled Study of LY3074828 in Subjects With Moderate-to- Severe Plaque Psoriasis
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo- Controlled Study of LY3074828 in Subjects With Moderate-to- Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: June 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

5 Total Publications

Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study.
Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study.
Journal: Expert opinion on biological therapy
Published: December 15, 2020
Similar Doctors
Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required
Before you request

H Lee Moffitt Cancer Center And Research

10920 McKinley Dr, 
Tampa, FL 
 (7.4 miles away)
813-745-8414
Languages Spoken:
English, German, Spanish
See accepted insurances
Accepting New Patients

Lucia Seminario-Vidal is a Dermatologist practicing medicine in Tampa, Florida. Dr. Seminario-Vidal is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, Erythema Multiforme, and Bone Marrow Aspiration. Dr. Seminario-Vidal is currently accepting new patients.

Expertise in
28
conditions
Dr. Seth B. Forman
Dermatology
Expertise in
28
conditions
Dr. Seth B. Forman
Dermatology
Referral may be required

Phdermatology

15416 N Florida Ave, 
Tampa, FL 
 (3.3 miles away)
813-960-2400
Languages Spoken:
English
See accepted insurances

Seth Forman is a Dermatologist practicing medicine in Tampa, Florida. Dr. Forman is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Atopic Dermatitis, Hidradenitis Suppurativa, Plaque Psoriasis, and Psoriasis. Dr. Forman is board certified in American Board Of Dermatology.

Expertise in
37
conditions
Dr. David A. Lam
Dermatology
Expertise in
37
conditions
Dr. David A. Lam
Dermatology
Referral required
Before you request

Academic Alliance In Dermatology

1005 E Boyer St, 
Tarpon Springs, FL 
 (14.5 miles away)
727-934-7638
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

David Lam is a Dermatologist practicing medicine in Tarpon Springs, Florida. Dr. Lam is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Kaposiform Hemangioendothelioma, Fetal Cystic Hygroma, Cerebral Cavernous Malformation, and Tufted Angioma. Dr. Lam is board certified in American Board Of Dermatology. Dr. Lam is currently accepting new patients.

Frequently Asked Questions about Dr. Ashley B. Cauthen

How do I make an appointment with Dr. Ashley B. Cauthen?

You can book an appointment with Dr. Ashley B. Cauthen by calling their office at 352-512-0092. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ashley B. Cauthen a top-rated expert for Sunburn?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ashley B. Cauthen is classified as an Distinguished expert for Sunburn, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ashley B. Cauthen specialize in?

While Dr. Ashley B. Cauthen is a Dermatology, they have specific expertise in Sunburn, Plaque Psoriasis, and Telangiectasia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Ashley B. Cauthen participate in research or clinical trials?

Yes. Dr. Ashley B. Cauthen has published 5 articles and abstracts on conditions like Sunburn. You can view a list of Dr. Ashley B. Cauthen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ashley B. Cauthen accept my insurance?

Dr. Ashley B. Cauthen accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 352-512-0092 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cauthen's expertise for a condition
ConditionClose
    View All 21 Advanced Conditions
    View All 44 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile